HY-P0303-1mg
|
MedChemexpress LLC
|
Crustacean cardioactive peptide?free acid [CAS 309247-84-5]
|
|
COVID-19-immunoregulation
|
|
HY-P0303-10mg
|
MedChemexpress LLC
|
Crustacean cardioactive peptide?free acid [CAS 309247-84-5]
|
|
COVID-19-immunoregulation
|
|
HY-P0303-5mg
|
MedChemexpress LLC
|
Crustacean cardioactive peptide?free acid [CAS 309247-84-5]
|
|
COVID-19-immunoregulation
|
|
HY-42682-50mg
|
MedChemexpress LLC
|
D(+)-Galactosamine (hydrochloride) [CAS 1772-03-8]
|
|
COVID-19-immunoregulation
|
|
HY-10264B-10mg
|
MedChemexpress LLC
|
Edoxaban (tosylate monohydrate) [CAS 1229194-11-9]
|
|
COVID-19-immunoregulation
|
|
HY-10264B-100mg
|
MedChemexpress LLC
|
Edoxaban (tosylate monohydrate) [CAS 1229194-11-9]
|
|
COVID-19-immunoregulation
|
|
HY-10264B-5mg
|
MedChemexpress LLC
|
Edoxaban (tosylate monohydrate) [CAS 1229194-11-9]
|
|
COVID-19-immunoregulation
|
|
HY-10264B-50mg
|
MedChemexpress LLC
|
Edoxaban (tosylate monohydrate) [CAS 1229194-11-9]
|
|
COVID-19-immunoregulation
|
|
HY-10264B-1mL
|
MedChemexpress LLC
|
Edoxaban (tosylate monohydrate) [CAS 1229194-11-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-10264A-10mg
|
MedChemexpress LLC
|
Edoxaban (tosylate) [CAS 480449-71-6]
|
|
COVID-19-immunoregulation
|
|
HY-10264A-5mg
|
MedChemexpress LLC
|
Edoxaban (tosylate) [CAS 480449-71-6]
|
|
COVID-19-immunoregulation
|
|
HY-10264A-1mL
|
MedChemexpress LLC
|
Edoxaban (tosylate) [CAS 480449-71-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-10264-10mg
|
MedChemexpress LLC
|
Edoxaban [CAS 480449-70-5]
|
|
COVID-19-immunoregulation
|
|
HY-10264-100mg
|
MedChemexpress LLC
|
Edoxaban [CAS 480449-70-5]
|
|
COVID-19-immunoregulation
|
|
HY-10264-5mg
|
MedChemexpress LLC
|
Edoxaban [CAS 480449-70-5]
|
|
COVID-19-immunoregulation
|
|
HY-10264-50mg
|
MedChemexpress LLC
|
Edoxaban [CAS 480449-70-5]
|
|
COVID-19-immunoregulation
|
|
HY-10264-1mL
|
MedChemexpress LLC
|
Edoxaban [CAS 480449-70-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-114911-25mg
|
MedChemexpress LLC
|
Feprazone [CAS 30748-29-9]
|
|
COVID-19-immunoregulation
|
|
HY-P7331-10ug
|
MedChemexpress LLC
|
FGF basic/bFGF, Human (154a.a)
|
|
COVID-19-immunoregulation
|
|
HY-P7331-100ug
|
MedChemexpress LLC
|
FGF basic/bFGF, Human (154a.a)
|
|
COVID-19-immunoregulation
|
|
HY-P7331-2ug
|
MedChemexpress LLC
|
FGF basic/bFGF, Human (154a.a)
|
|
COVID-19-immunoregulation
|
|
HY-P7331-50ug
|
MedChemexpress LLC
|
FGF basic/bFGF, Human (154a.a)
|
|
COVID-19-immunoregulation
|
|
HY-109008-10mg
|
MedChemexpress LLC
|
Nacubactam [CAS 1452458-86-4]
|
|
COVID-19-immunoregulation
|
|
HY-109008-100mg
|
MedChemexpress LLC
|
Nacubactam [CAS 1452458-86-4]
|
|
COVID-19-immunoregulation
|
|
HY-109008-5mg
|
MedChemexpress LLC
|
Nacubactam [CAS 1452458-86-4]
|
|
COVID-19-immunoregulation
|
|